EBF 2025: A generic immunogenicity assay for the detection of anti-drug antibodies (ADA)in mouse serum samples

Discover how Frontage developed and qualified a generic ECLIA bridging immunogenicity assay to efficiently detect anti-drug antibodies (ADA) against multiple human IgG subclasses in mouse serum. This streamlined, non-clinical ADA solution reduces the need for bespoke assays while helping sponsors better interpret exposure and safety findings.

"*" indicates required fields

X/Twitter